Tag:
Unigene Laboratories
Latest Headlines
Latest Headlines
UPDATED: Supreme Court upholds Unigene's nasal delivery patent
Unigene Laboratories can hold on to its patent for Fortical, after the Supreme Court denied Apotex's petition this week.
Unigene regains treatment rights as GSK backs out
Unigene Laboratories ( $UGNE ) says it has regained the global rights to an oral formulation of a parathyroid hormone analog to treat osteoporosis in postmenopausal women from GlaxoSmithKline ( $GSK ).
Novartis falls short in trial for oral osteoporosis drug
Novartis Pharma's ( $NVS ) oral formulation of calcitonin to treat for post-menopausal osteoporosis failed to meet its primary endpoint or key secondary endpoints in a crucial critical trial....
Unigene ties up with Nordic for peptide meds in blockbuster markets
Building on its banner pacts with GlaxoSmithKline and upstart Tarsa Therapeutics, Unigene Laboratories ($UGNE) has joined forces with Danish biotech Nordic Bioscience to develop Unigene's oral
Unigene forms joint venture to develop oral peptide drugs with Nordic Bioscience
Unigene Laboratories has hammered out a new pact to propel development of novel peptide drugs using its oral formulation technology. Nordic Bioscience, a Danish drug and diagnostic development
Unigene, Tarsa score Ph3 win with oral peptide drug
Unigene Laboratories ($UGNE) has garnered more clinical validation for its delivery and manufacturing technology that enables peptide drugs to be taken orally. Venture-backed Tarsa Therapeutics, in
Unigene Labs raises $13.6M in debt restructuring
Boontoni, NJ-based Unigene Laboratories has restructured its debt, raising $13.6 million and giving Victory Park Capital Advisors, the sole investor in the transaction, the right to name two people
New biotech launched with $24M, PIII drug
A trio of venture capital firms has chipped in $24 million to fund a new biotech company, which is starting out with a late-stage development program licensed in from Unigene Laboratories. Unigene
Booming Chinese market lures Unigene joint venture
Unigene is racing to complete construction of new facilities in China that will house its joint venture with a Chinese pharma company. The joint venture plans to pursue R&D work as well as drug
